Off-label GLP-1 use jumped 15-fold in 4 years: 5 notes
Off-label GLP-1 use increased 15-fold between 2021 and 2025, according to a study published Sept. 22 in Obesity. Researchers analyzed medical records from more than 92 million U.S. adults to examine GLP-1 use among patients without a documented condition that would make them eligible for the medications, such as obesity or diabetes. Here are five […] The post Off-label GLP-1 use jumped 15-fold in 4 years: 5 notes appeared first on Becker's Hospital Review | Healthcare News & Analy...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.